Ads
related to: neurodegenerative conditions- How to Identify PBA?
Do You Know The Symptoms Of PBA?
Learn How To Identify
- The Impact of PBA?
How PBA Affects Patient's Lives
Learn About The Substantial Impact
- How to Identify PBA?
Search results
Late-Night Danger: Scientists Discover Link Between Common Sleep Condition and Epilepsy
SciTechDaily· 7 days agoResults offer a deeper understanding of the intricate link between sleep disorders and epilepsy. According to a new study funded by the National Institutes of Health (NIH) and published in Sleep ...
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
Benzinga· 2 days agoOn Monday, privately held QurAlis Corporation entered into an exclusive license agreement with Eli...
A Young Father Was Diagnosed with ALS and Fought to Change the Fate of the Disease. Now His Story Is...
People Magazine· 6 hours agoBrian Wallach is no ordinary guy. The father of two and lawyer — former White House counsel for...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoQurAlis Grants Lilly Exclusive Global License for QRL-204, a Potentially First-in-Class Precision Therapy That Restores UNC13A Function in ALS and FTD PR Newswire CAMBRIDGE, Mass., June 3, 2024 QRL-204 is a splice-switching ASO generated through
The future of drug testing: Vascularized organ-on-a-chip technologies
Medical Xpress· 2 days agoResearchers from Shanghai University and the University of California Los Angeles have made significant strides in the field of in vitro vascularized organ-on-a-chip systems, offering a promising ...
Early-stage research suggests new way to fight Alzheimer’s disease progression
MedicalNewsToday via AOL· 3 days agoNew preclinical-stage research suggests that targeting a specific protein in the brain could help...
Emphasizing Heavy Lifting and Effective Training Cycles
Men's Journal· 6 hours agoThe difference between heavy lifting and effective training cycles in the weight room
Building Alzheimer's care Pathways: A Discussion with the Cleveland Clinic
Becker’s Hospital Review· 7 days agoDuring an interactive session at Becker's 14th Annual Meeting, leaders from Cleveland Clinic discussed the importance of early assessment and diagnosis to support the treatment of Alzheimer's ...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 6 days agoBiogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for QALSODY® (tofersen ...
FDA Launches Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program |...
JD Supra· 19 hours agoThe START program, led by the Center for Biologics Evaluation and Research (“CBER”) and Center for Drug Evaluation and Research (“CDER”), was designed to “help further accelerate the development ...
